Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC)Recruiting
NCT06796803Phase 2, Phase 3Updated Jul 17, 2026
Sponsor: Shanghai Zhongshan Hospital
Potentially Resectable Hepatocellular Carcinoma
China
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCCRecruiting
NCT06788990Phase 2, Phase 3Updated Jul 17, 2026
Sponsor: Bicara Therapeutics
Metastatic Head and Neck Squamous Cell Carcinoma · Recurrent Head and Neck Squamous Cell Carcinoma
United States, Argentina, Australia, Austria, Belgium +21 more
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCTRecruiting
NCT05429632Phase 3Updated Jul 17, 2026
Sponsor: Priothera SAS
Adult Acute Myeloid Leukemia
United States, Argentina, Brazil, France, Germany +9 more
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental DisorderRecruiting
NCT07224581Phase 3Updated Jul 17, 2026
Sponsor: GRIN Therapeutics, Inc.
GRIN-related Neurodevelopmental Disorder
United States, Belgium, France, Germany, Italy +5 more
Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH)Recruiting
NCT07245264Phase 2, Phase 3Updated Jul 17, 2026
Sponsor: St. Olavs Hospital
Chronic Subdural Hematoma
India
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic ArthritisRecruiting
NCT06668181Phase 3Updated Jul 17, 2026
Sponsor: UCB Biopharma SRL
Enthesitis-related Arthritis · Juvenile Psoriatic Arthritis
Canada, France, Germany, Poland, Spain +1 more
Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CRRecruiting
NCT02416388Phase 2, Phase 3Updated Jul 17, 2026
Sponsor: University Hospital, Angers
Acute Myeloid Leukemia (AML)
France
Effect of Sedative and Anxiolytic Premedication on Children Experience After General AnesthesiaRecruiting
NCT05681572Phase 3Updated Jul 17, 2026
Sponsor: University Hospital, Montpellier
Anesthesia
France
500-mg Versus 1000-mg Ceftriaxone for Uncomplicated Gonorrhea InfectionRecruiting
NCT07710118Phase 3Updated Jul 17, 2026
Sponsor: National Taiwan University Hospital
Gonorrhea Infection
Taiwan
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar PustulosisRecruiting
NCT07219420Phase 3Updated Jul 17, 2026
Sponsor: UCB Biopharma SRL
Palmoplantar Pustulosis
United States, Canada, China, Czechia, Denmark +8 more
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With CancerRecruiting
NCT06513962Phase 3Updated Jul 17, 2026
Sponsor: Children's Oncology Group
Hematopoietic and Lymphatic System Neoplasm · Malignant Solid Neoplasm
United States, Canada
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)Recruiting
NCT07284602Phase 3Updated Jul 17, 2026
Sponsor: PureTech
Idiopathic Pulmonary Fibrosis (IPF)
United States
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLyRecruiting
NCT03959085Phase 3Updated Jul 16, 2026
Sponsor: Children's Oncology Group
B Acute Lymphoblastic Leukemia · B Lymphoblastic Lymphoma · Central Nervous System Leukemia · Mixed Phenotype Acute Leukemia
United States, Australia, Canada, New Zealand, Puerto Rico
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing LossRecruiting
NCT05382338Phase 3Updated Jul 16, 2026
Sponsor: Children's Oncology Group
Childhood Medulloblastoma
United States, Canada
Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)Recruiting
NCT06891950Phase 3Updated Jul 16, 2026
Sponsor: Butantan Institute
Dengue
Brazil
Efficacy and Safety Evaluation of SMO1 in Patients With Retinal Vein Occlusive Macular EdemaRecruiting
NCT07708142Phase 3Updated Jul 16, 2026
Sponsor: SANGMYUNG innovation
Retinal Vein Occlusion With Macular Edema
South Korea
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer PatientsRecruiting
NCT05053867Phase 3Updated Jul 16, 2026
Sponsor: M.D. Anderson Cancer Center
Pulmonary Hemorrhage · Cancer
United States
Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab "Immune Sandwich" Regimen Versus Full-Course Immunotherapy for Locally Advanced Nasopharyngeal CarcinomaRecruiting
NCT07706985Phase 3Updated Jul 16, 2026
Sponsor: Sun Yat-sen University
Nasopharyngeal Carcinoma (NPC)
China
Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)Recruiting
NCT07149649Phase 2, Phase 3Updated Jul 16, 2026
Sponsor: Swiss Cancer Institute
Metastatic NSCLC - Non-Small Cell Lung Cancer
Switzerland
An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCEDRecruiting
NCT07519902Phase 3Updated Jul 16, 2026
Sponsor: Dompé Farmaceutici S.p.A
Persistent Corneal Epithelial Defect
United States, Argentina, Czechia, France, Germany +9 more
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaRecruiting
NCT05757102Phase 3Updated Jul 16, 2026
Sponsor: GlaxoSmithKline
Asthma
United States, Argentina, Australia, Chile, Israel +4 more
A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-Line TherapyRecruiting
NCT07487896Phase 3Updated Jul 16, 2026
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Advanced Esophageal Squamous Cell Carcinoma
China
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of RecurrenceRecruiting
NCT03583710Phase 3Updated Jul 16, 2026
Sponsor: M.D. Anderson Cancer Center
ENSAT Stage I Adrenal Cortex Carcinoma · ENSAT Stage II Adrenal Cortex Carcinoma · ENSAT Stage III Adrenal Cortex Carcinoma
United States, France, Germany, Poland, Sweden
A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02)Recruiting
NCT07554456Phase 2, Phase 3Updated Jul 16, 2026
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Esophageal Squamous Cell Carcinoma
China
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid LeukemiaRecruiting
NCT07022678Phase 3Updated Jul 16, 2026
Sponsor: Children's Oncology Group
Acute Myeloid Leukemia · Recurrent Acute Myeloid Leukemia
United States

Previous page Next page